Agape ATP Corp. (ATPC) Shares Surge 64.86% to $0.12 in After-Hours Trading
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3h ago
0mins
Source: Benzinga
- Stock Price Surge: Agape ATP's shares jumped 64.86% to $0.12 in after-hours trading on Wednesday, despite no identified catalysts, raising market interest and potentially impacting investor confidence.
- Market Performance Analysis: The stock closed at $0.07 during regular trading, up 6.06%, but has fallen 94.81% over the past 12 months, indicating a persistently negative long-term trend that warrants caution from investors.
- Operational Statement: In a December 2025 statement, Agape ATP confirmed that business operations continue as usual and stated that no material undisclosed information could explain the stock's volatility, aiming to stabilize market sentiment.
- Management Focus: Founder and Global CEO Kok Choong emphasized the company's commitment to diversifying into health and wellness and sustainable green energy sectors to provide sustainable equity performance value for investors.
Analyst Views on ATPC
About ATPC
Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
